130 related articles for article (PubMed ID: 4372368)
1. Protection of mice from malignant tumor implants by enucleated tumor cells.
Sethi KK; Brandis H
J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
[No Abstract] [Full Text] [Related]
2. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
Paranjpe MS; Boone CW
J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
[No Abstract] [Full Text] [Related]
3. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
Rogers MJ; Law LW
Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
[No Abstract] [Full Text] [Related]
4. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.
Drapkin MS; Appella E; Law LW
J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833
[No Abstract] [Full Text] [Related]
5. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors.
Blakeslee JR; von Muenchhausen W; Cox HR
J Med; 1973; 4(4):233-47. PubMed ID: 4358481
[No Abstract] [Full Text] [Related]
6. Analysis of minimal functions of simian virus 40. I. Oncogenic transformation of Syrian hamster kidney cells in vitro by photodynamically inactivated SV40.
Seemayer NH; Hirai K; Defendi V
Int J Cancer; 1973 Sep; 12(2):524-31. PubMed ID: 4365095
[No Abstract] [Full Text] [Related]
7. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
Ting CC; Rodrigues D; Herberman RB
Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
[No Abstract] [Full Text] [Related]
8. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
Glaser M
J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
[No Abstract] [Full Text] [Related]
9. Early growth of experimental tumors and the onset of concomitant immunity.
karakousis CP; Paolini NS; Sharma SD; Moore RH
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):211-7. PubMed ID: 6284514
[No Abstract] [Full Text] [Related]
10. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
Häkkinen I; Halonen P
J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
[No Abstract] [Full Text] [Related]
11. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
Phillips ME
J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
[No Abstract] [Full Text] [Related]
12. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
Henriksen O; Law LW; Appella E
J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
[TBL] [Abstract][Full Text] [Related]
13. Survival of host mice and induced resistance to transplantable ascites tumors.
Kimura Y; Tanino T
Jpn J Exp Med; 1966 Aug; 36(4):371-405. PubMed ID: 4291054
[No Abstract] [Full Text] [Related]
14. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
Zola H
Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
[TBL] [Abstract][Full Text] [Related]
15. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
16. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
Law LW; Takemoto KK; Rogers MJ; Ting RC
J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
Glaser M
Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870
[No Abstract] [Full Text] [Related]
18. [Antitumoral immunity induced by the administration of homologous and isologous tumoral cells treated by moderate heating].
Bourdon G; Halpern B
C R Acad Hebd Seances Acad Sci D; 1976 Apr; 282(16):1571-6. PubMed ID: 820462
[TBL] [Abstract][Full Text] [Related]
19. Induction of active immune state by multinucleate tumour cells in mice.
Liao SK; Carr DH
Experientia; 1973 May; 29(5):597-9. PubMed ID: 4354198
[No Abstract] [Full Text] [Related]
20. Tumorigenicity and antigenicity of mouse cells infected with Simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients.
Wright PW; Smith HS; McCoy J
J Natl Cancer Inst; 1973 Sep; 51(3):951-9. PubMed ID: 4355223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
